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Abstract
Transforming growth factor-beta superfamily regulates many aspects of reproduction in the female.
We identified a novel member of this family, growth-differentiation factor 8 (GDF-8) in the 72 h
post coital uterine fluid of the golden hamster by proteomic techniques. Uterine GDF-8 mRNA
decreased as pregnancy progressed while its active protein peaked at 72 h post coitus (hpc) and
thereafter stayed at a lower level. At 72 hpc, the GDF-8 transcript was localized to the endometrial
epithelium while its protein accumulated in the stroma. Exogenous GDF-8 slowed down
proliferation of primary cultures of uterine smooth muscle cells (SMC) and endometrial epithelial
cells (EEC). In addition, GDF-8 attenuated the release of LIF (leukaemia inhibiting factor) by EEC.
As for the embryo in culture, GDF-8 promoted proliferation of the trophotoderm (TM) and
hatching but discouraged attachment. Our study suggests that GDF-8 could regulate the behavior
of preimplantation embryos and fine-tune the physiology of uterine environment during pregnancy.
Background
The TGF-β superfamily encompasses a large number of
structurally related molecules such as TGF-β1-3, growth-
differentiation factors (GDF), nodal molecules, activins,
inhibins and bone morphogenetic proteins (BMP) [1,2].
In reproduction, these molecules function in regulating
immune responses in the uterus during embryogenesis
and embryonic implantation [2-4]. It has been suggested
that some of these molecules can be used as markers to
screen various potential gestational problems like miscar-
riage, placental pathology and pre-eclampsia [2,5,6]. So
the emergence of novel members of this family could
open up more therapeutic choices. In this study, we
reported the identification of a novel member of TGF-β
superfamily, GDF-8 in the pregnant uterus and studied its
functional significance in the uterus of the golden ham-
ster.
GDF-8, also known as myostatin, was first identified in
skeletal muscle [7]. As the name implies, its primary
action is on skeletal muscle growth [7,8]. GDF-8 is synthe-
sized as a precursor made up of 375 amino acids and
released in an active glycosylated form (26 kDa) into the
plasma [9] where it binds to the activin receptor 2B
(ACVR2B) to exert its effect [8]. Recently its presence and
cyclical expression in the non-pregnant uterus of the rat
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has been reported [10]. This expression pattern is regu-
lated by steroid hormones [10] but its function is not
known.
We detected and localized in the hamster the expression
of GDF-8 mRNA and its active peptide in the uterus
throughout the course of pregnancy from 60 hpc (D2.5)
when the embryo started to enter the uterus, to D15
shortly before delivery. In this species, embryos complete
the oviduct-uterine transit by 72 hpc (D3) in preparation
for attachment that begins at 78 hpc; implantation follows
and is completed on D5 [11,12]. We studied the effect of
GDF-8 on proliferation and differentiation of myometrial
smooth muscle, endometrial epithelium and develop-
ment of the blastocyt.
Methods
All materials were purchased from Sigma (St Louis, MO,
USA) unless otherwise stated and all procedures were car-
ried out at room temperature unless specified.
Experimental animals
Randomly bred golden hamsters (Mesocricetus auratus)
supplied by and housed in the Laboratory Animal Services
Centre of The Faculty of Medicine, The Chinese University
of Hong Kong were handled in compliance with a proto-
col approved by the Animal Research Ethics Committee of
the Institution. The hamsters were kept under a photope-
riod of 14 hours light: 10 hours darkness (lights on at 11
am). On the day of estrus, a 6-8 weeks old female hamster
with two consecutive normal cycles according to vaginal
discharge was mated for 15 min with a male and thereaf-
ter kept individually in a breeding cage. The day of mating
was designated day 0 of pregnancy.
Sample collection
At designated time points after mating, female hamsters
were sacrificed with an overdose of ketamine/xylazine.
Uterine horns were removed and each was flushed with 1
ml 0.85% saline containing proteinase inhibitors (Roche,
Mannheim, Germany). The flushing was centrifuged at
12000 g for 10 min at 4°C and the supernatant kept. The
endometrium was then peeled off from the uterus. The
flushing and endometrial tissues were stored separately at
-80°C. Intact uteri for histological studies were fixed in
4% paraformaldehyde overnight, dehydrated in graded
ethanol, embedded in paraffin and processed for immu-
nohistochemistry and in situ hybridization (ISH).
Extraction of protein and RNA
Uterine flushing or endometrial tissue was incubated on
ice for 3 h in 1 ml lysis buffer made up of 7 M urea, 65 mM
CHAPS (USB Corporation, Cleveland, OH, USA), 2 M
thiourea, 1% NP-40, 1% TBP reducing agent (Bio-Rad
Laboratories, Hercules, CA, USA) and proteinase inhibi-
tors. The mixture was centrifuged at 12000 g for 20 min at
4°C and the supernatant was kept. Protein concentration
was determined with Modified Bradford reagent (Bio-
Rad, Hercules, CA, USA). Total RNA was extracted from
endometrial tissue by using the Promega SV total RNA iso-
lation kit (Promega, Madison, WI, USA) according to
manufacturer's instructions. The RNA extracted was
reversely transcribed with Superscript RNase-H Reverse
transcriptase (Invitrogen, Carlsbad, CA, USA). The cDNA
was stored at -20°C until use.
2-Dimensional electrophoresis
Two-dimensional electrophoresis (2-DE) was carried out
as described in Liu et al. [13]. One hundred milligram of
the samples was used for first dimension separation on an
Ettan® IPGphor® Isoelectric Focusing Unit (GE Healthcare
Life Sciences, Uppsala, Sweden) using rehydrated 13 cm
immobiline strip (GE Healthcare Bio-Sciences, Uppsala,
Sweden) and co-run with internal protein markers (Bio-
Rad, Hercules, CA, USA). After first dimensional separa-
tion, the gel strip was soaked sequentially in equilibrium
buffer pH 6.8 made up of 6 M urea, 30%(w/v) glycerol,
2%(w/v) SDS, 0.05 M Tris-HCl, 2%(w/v) DTT for 30 min
and then in 2% iodoacetamide for 30 min. Second
dimension separation in 10% SDS gel (18 × 16 cm) was
carried out in an ISO-DALT apparatus (Hoefer Scientific
Instruments, Amersham Biosciences, San Francisco, CA,
USA) operated at a constant current of 60 mA. A Tris-tri-
cine dissociating buffer system was applied. The gel was
preserved sequentially in a mixture comprising 40% etha-
nol and 10% acetic acid, followed by 30% ethanol and
stained with silver nitrate. Molecular masses and pI values
of the protein spots were determined by co-running with
standard markers (MBI Fermantas, Vilnius, Lithuania).
Image analysis and in-gel digestion
Protein spots of interest were destained with 30 mM
potassium ferricyanide and 100 mM sodium thiosulfate,
washed with 50% acetonitrile (ACN)/25 mM ammonium
bicarbonate at pH 8.0 and soaked in 100% ACN. The gel
spots were then dried in a SpeedVac evaporator
(UniEquip, Martinsried, Germany), rehydrated in cold
trypsin (Promega, Madison, WI, USA) at a concentration
of 15 mg/ml (w/v) in 25 mM ammonium bicarbonate,
pH 8.0 and incubated at 37°C for 16-24 h. The peptide
was then extracted with 50% ACN/5% trifluoroacetic acid
(TFA) and reconstituted in 50% ACN/0.1% TFA. The
reconstituted extract (0.5 μl) was then mixed with 0.5 μl
of fresh cyano-matrix made up of a saturated solution of
cyano-4-hydroxy-cinnamic acid (CHCA) in 50% ACN
and dispensed on a MALDI plate. The protein sample was
analyzed in a TOF mass spectrometer (Voyager-DE PRO
Biospectrometry, Applied Biosystems, Foster City, CA,
USA). For database search, known contamination peaks
such as products of autoproteolysis and keratin wereReproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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purged before a protein mass fingerprint search was per-
formed on the MASCOT software (Matrix Science, Lon-
don, UK) in the NCBI database. Up to one missed tryptic
cleavage was considered and a mass accuracy of 500 ppm
was applied for all tryptic-mass searches. Protein identifi-
cation was confirmed by using the MS-Fit software http://
prospector.ucsf.edu. Several proteins of interest were
identified and GDF-8 was selected for further investiga-
tion.
Confirmation of GDF-8 in 2-D gel
Uterine fluid protein separated in 2-D gel as described
above was electroblotted onto nitrocellulose membrane.
The membrane was blocked with 5% (w/v) non-fat milk
(Bio-Rad Laboratories, Hercules, CA, USA) for 2 h prior to
interacting with goat polyclonal anti-GDF-8 antibody
(1:500) (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
at 4°C overnight. After washing with PBS-T (PBS with
0.05% v/v Tween20), the membrane was incubated with
HRP-conjugated donkey anti-goat antibody (1:1000)
(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and vis-
ualized by applying the ECL Plus kit (GE Healthcare, Bio-
Sciences, Uppsala, Sweden).
Molecular cloning of hamster GDF-8
GDF-8 mRNA in hamster uterus was amplified with Taq
polymerase (GE Healthcare Bio-Sciences, Uppsala, Swe-
den) and identified by 2% agarose gel electrophoresis.
The primer sequences of GDF-8 were: forward: GTGGAT-
GGAAAACCCAAATG; and reverse: TGGTCCTGGGAAG-
GTTACAG. The 342 bp product was excised and purified
with high pure PCR product purification kit (Roche, Man-
nheim, Germany). The purified PCR product was cloned
by using TOPO TA cloning kit dual promoter (Invitrogen,
Carlsbad, CA, USA) according to manufacturer's instruc-
tions. After transformation, single colonies were purified
with blue/white selection. The plasmid was purified with
HighPure plasmid purification kit (Invitrogen, Carlsbad,
CA, USA) and sequenced by the Genomic Centre of the
University of Hong Kong. The GDF-8 sequence was used
to synthesize riboprobe for ISH and design probe for real-
time PCR.
In situ hybridization
To synthesize digoxigenin (DIG)-labeled GDF-8 ribo-
probe for ISH, plasmid containing a 302 bp cDNA frag-
ment was linearized with ApaI or PstI, extracted with
phenol/chloroform and precipitated with ethanol. The
linearized plasmid served as the template for DIG labeling
with either T7 or SP6 RNA polymerase in combination
with a DIG-RNA labeling kit (Roche, Mannheim, Ger-
many). Deparaffinized sections of the uterus were treated
with proteinase K for 15 min and prehybridized in hybrid-
ization buffer made up with 4 × SSC (Research Organics,
Inc.; Cleveland, OH, USA), 1 × Denhardt's solution, 10
mM DTT, 1 mg/ml yeast tRNA, 10% dextran sulfate and
40% deionized formamide at 37°C for 1 h. The sections
were hybridized with DIG-labeled riboprobe specific for
GDF-8 (10 ng/ml) at 48°C overnight in a hybridization
buffer that contained 1 mg/ml denatured herring sperm
DNA (Roche, Mannheim, Germany). After hybridization,
the sections were treated with RNase and rinsed in a series
of SSC. Incubation with anti-DIG-alkaline phosphatase
antibody followed and reaction signals were visualized
with NBT/BCIP (Roche, Mannheim, Germany). Sections
for negative control were hybridized with the sense probe.
Immunohistochemistry
Deparaffinized sections of uterine horn were subjected to
quenching with 3% hydrogen peroxide in methanol and
antigen retrieval in 10 mM sodium citrate (pH 6) at 60°C
for 40 min. This was followed by blocking with 5%
bovine serum albumin for 30 min and a series of incuba-
tions first with goat polyclonal anti-GDF-8 antibody
(1:500) (Santa Cruz Biotechnology Inc, Santa Cruz, CA,
USA) at 4°C overnight, and then biotinylated anti-goat
antibody (1:500) for 2 h. GDF-8 immunoreactivity was
visualized by applying the avidinbiotin-peroxidase com-
plex (ABC, Vector Laboratories, Inc.; CA, USA) coupled
with diaminobenzidine (DAB; Zymed Laboratories, Inc.;
South San Francisco, CA, USA).
Real-time PCR
cDNA of uterus and endometrium obtained by reversed
transcription was used for real time PCR of GDF-8. A 20
μl mixture was prepared according to the manufacturer's
manual. It contained 10 μl Taqman® universal PCR master
mix (Applied Biosystems, Foster City, CA, USA), 4 μl ster-
ile water, 1 μl 20× Taqman probe of the target gene
(Applied Biosystems, Foster City, CA, USA) and 5 μl
cDNA. The mixture was subjected to PCR in a light cycler
(ABI 7700, Applied Biosystems, Foster City, CA, USA)
with conditions recommended by the manufacturer.
Upon completion, the PCR data were analyzed by ABI
SDS Version 2.1. The cycle threshold (CT) was used to
compute the fold of change of gene expression at specific
time points according to the 2-ΔΔC
T  method [14].
Sequences of primers and probes of target genes are given
in Table 1.
Table 1: Sequences of primers and probes of target genes
Target gene Sequence
β-actin Forward: GTACCACTGGCATTGTGATGGA
Reverse: GAGAGCGTAGCCCTCATAGATG
Probe: CAGTGTGGGTGACCCC
gdf8 Forward: TGTGCTGGCAGTCCTTTCC
Reverse: GAGAAAGGCCAGTACGAATGCT
Probe: CACACCTGGGTTCTCTReproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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Enzyme-linked immunoabsorbent assay for active GDF-8
The expression of active GDF-8 in uterus during preg-
nancy was quantified with ELISA. Three hundred micro-
gram of uterine protein dissolved in carbonate-
bicarbonate buffer (pH 7.4) fortified with 15 mM
Na2CO3, 35 mM NaHCO3, 3 mM NaN3 was dispensed
into the wells of a 96-well plate and left at 4°C overnight.
The plate was then washed with PBS-T, blocked with 3%
bovine serum albumin (BSA) at 4°C overnight and then
immunoreacted overnight with anti-myostatin (1:150;
Chemicon, Temecula, CA, USA) at 4°C. This was followed
by probing with alkaline phosphatase-conjugated donkey
anti-rabbit antibody (1:1000) at 37°C for 1 h. After thor-
ough washing with PBST, 100 ul nitrophenyl-phosphate
(NPP) at 2 mg/m1 in a substrate buffer made up of 0.125
mM NaCO3 and 1 mM MgCl2 was added to each well and
incubated at 37°C for 30 min. The reaction was stopped
with 10 μl 1N NaOH. The amount of active GDF-8 in the
uterus was determined at OD415 with a Microplate
Reader (Model 680, Bio-Rad Laboratories, Hercules, CA,
USA).
Myometrial smooth muscle cell (MSMC) culture and 
quantification
To study the effect of GDF-8 on myometrial smooth mus-
cle cell (MSMC), a primary culture was set up with proce-
dures modified from Shynlova et al. [15]. All chemicals
except BSA were purchased from Gibco of Auckland in
New Zealand. Uterine horns from a 6-week-old female
hamster were blotted free of blood, slit longitudinally,
washed and placed in warm Hank's Balanced Salt Solu-
tion (HBSS1, pH 7.4) which contained 0.908 g/l MgSO4,
0.185 g/l CaCl2, 25 mM HEPES, and Penicillin-Strepto-
mycin (P/S). The endometrial layer was gently teased off
with fine forceps. The myometrium was washed in HBSS2
(HBSS1 without Mg2+  and Ca2+), trimmed into small
pieces and disintegrated with shaking in a solution made
up of 1 mg/ml collagenase type II, 0.15 mg/ml DNase I,
0.1 mg/ml soybean trypsin inhibitor, 10% Fetal Bovine
Serum (FBS) and 1 mg/ml BSA in HBSS2 at 37°C for 1 h.
The cells were dispersed by passing through a 40 μm cell
strainer. Enzyme digestion was repeated at 4°C overnight.
Dissociated cells were precipitated by centrifugation at
1200 g for 10 min. The pellet was washed with HBSS2 that
contained 10% FBS and re-suspended in Dulbacco's
Mixed Eagle's Medium - Formula 12 (DF12) supple-
mented with 10% charcoal treated FBS, 1 μM estradiol
and 20 μM progesterone at a concentration of 2.5 × 104
cells per ml. Five hundred microlitres of the cell suspen-
sion was dispensed into each well of a 4-well plate (Nunc
A/S, Roskilde, Denmark) and incubated for 24 h at 37°C.
The heat-sterilized coverslips in the wells had been
cleaned, soaked in 0.2N HCl for 30 min and degreased in
acetone overnight. Recombinant GDF-8 peptide (R&D,
Minneapolis, MN, USA) was added to the cells at a con-
centration of 5 μg/ml in phenol-red free Dulbacco's Mixed
Eagle Medium (DMEM) supplemented with 10% char-
coal-treated FBS and 100 U/ml P/S for 60 h or 72 h. Upon
completion of treatment, cells were washed with PBS,
fixed in 4% paraformaldehyde, permeabilized with 0.1%
Triton X-100 and blocked with 3% BSA. Cells were
labelled with mouse monoclonal anti-α-smooth muscle
actin (SMA) antibody (1:200) (Calbiochem, San Diego,
CA, USA) and goat polyclonal anti-PCNA (1:200) (Santa
Cruz Biotechnology Inc, Santa Cruz, CA, USA) at 4°C
overnight, followed by incubation in sequence for 1 h
with FITC-conjugated anti-mouse antibody (1:200) (Jack-
son ImmunoResearch Laboratory, West Groove, PA, USA)
and Alexa Flour 555 conjugated anti-goat antibody
(1:200) (Invitrogen, Carlsbad, CA, USA). Nuclei were
stained with 6-diamidino-2-phenylindole (DAPI) con-
tained in the UltraCruz™ Mounting Medium (Santa Cruz
Biotechnology Inc, Santa Cruz, CA, USA). For negative
control, the primary antibodies were omitted. Slides were
examined with fluorescence microscope and imaged at
20×. Nine to ten frames were randomly taken for each
coverslip from which 995-1923 cells were counted with
the Metamorph (version 5.0, Molecular Devices Corpora-
tion, PA, USA) or Neurolucidar (Microbrightfield, Col-
chester, VT, USA) imaging systems. Total numbers of
DAPI-stained cells, SMA-positive cells and PCNA cum
SMA-positive cells were scored from which the percent-
ages of SMA- and proliferating SMA-labeled cells were cal-
culated.
Endometrial epithelial cell (EEC) culture and 
quantification
The procedure for EEC culture was modified from McCor-
mack and Glasser [16]. Uterine horns from 6-week old
female hamster were blotted, slit longitudinally and
washed in PBS free of Mg2+ and Ca2+. They were incubated
with shaking firstly in a mixture of trypsin (0.5%, type III
from bovine pancreas) and pancreatin (2.5%) dissolved
in PBS free of Mg2+ and Ca2+ at 4°C overnight, and then at
20°C for 1 h in HBSS2 fortified with 10% FCS. The
medium which contained the EEC was collected. This
process was repeated to harvest more ECC. The pooled
medium was centrifuged at 500 g for 5 min and the cell
pellet was re-suspended in the same medium. After the
cell clumps settled by gravity, the supernatant was
removed and the process was repeated until the superna-
tant became clear. The EEC preparation so obtained was
free of glandular epithelium, stroma, blood cells and
myometrial cells when inspected under the microscope at
400×. The EEC were then pelleted by centrifugation, re-
suspended in complete medium made up of DMED/F12,
2.5% FCS, 2.5% Nu Serum, 1 μM estradiol, 20 μM proges-
terone, 15 mM HEPES, and 1% P/S at 100 U/ml and
seeded at a density of 1200 cells/mm2 onto Engelbreth
Holm Swarm tumor matrix (Matrigel) coated coverslips inReproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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a 24-well plate (BD Biosciences, San Jose, CA, USA). After
24 h, unattached cells were removed and the medium was
changed daily for 2 days. GDF-8 at a final concentration
of 5 μg/ml was added and the EEC was incubated for a fur-
ther 36 h. The cells were then fixed in 4% PFA and immu-
noreacted with mouse anti-keratin antibody and goat
anti-PCNA antibody (both at 1:200, Santa Cruz Biotech-
nology Inc., Santa Cruz, CA, USA) to identify proliferating
EEC as described for MSMC. The respective secondary
antibodies were Alexa Flour 488 conjugated anti-mouse
(1:150) and Alexa Flour 555 conjugated anti-goat at
1:100) (Invitrogen, Carlsbad, CA, USA). Cells that were
positive for DAPI, keratin (EEC) and keratin cum PCNA
(proliferating EEC) were scored and processed as
described for MSMC.
ELISA for LIF in cultured media
The amount of LIF released into the EEC culture medium
was determined as described for active GDF-8. The pri-
mary antibody used was goat polyclonal anti-LIF (1:100,
Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA) and
the secondary antibody donkey anti-goat antibody
(1:1000) conjugated to alkaline phosphatase (Jackson
ImmunoResearch Laboratory, West Groove, PA, USA).
Intensity of immunoreactivity was revealed with nitroph-
neyl-phosphate and measured at OD415 (Model 680
ELISA Reader, Bio-Rad Laboratories, Hercules, CA, USA).
Recovery and culture of embryos
Pregnant female hamsters were euthanized at 72 hpc. The
uterine horns were excised and flushed to recover
embryos which were cultured for 48 h with/without 0.75
μg/ml recombinant mouse GDF-8 (R&D Systems, Inc.,
Minneapolis, USA) in HECM-2h (hatching medium). The
hatching medium contained 116.5 mM NaCl, 3.2 mM
KCl, 2.0 mM CaCl2, 0.5 mM MgCl2.6H2O, 25 mM
NaHCO3, 10 mM sodium lactate, 0.25 mM sodium pyru-
vate, 1 mM glutamine, 0.1 mg/ml polyvinyl alcohol, 100
units/ml Penicillin-Streptomycin (Invitrogen, Carlsbad,
CA, USA), 0.001 g/ml phenol red, 0.5 mM succinate, 0.1
mM alanine, 0.1 mM asparagine, 0.1 mM aspartate, 0.1
mM glutamate, 0.1 mM glycine, 0.1 mM proline, 0.1 mM
serine, 0.003 mM panthothenate, 0.005 mM choline
chloride, 0.003 mM inositol and 3 mg/ml BSA.
Blastocysts were cultured in a 15 μl droplet of hatching
medium overlaid with 1.5 ml mineral oil in a 35 × 10
mm2  tissue culture dish (Falcon, Becton Dickinson
Labware, NJ, USA) at 37°C in an atmosphere of 5% CO2
balance air. After 24 and 48 h, embryos were digitally-
imaged (Miticam 2300, Motic China Group Co. Ltd, Xia-
men, China) for measurement of area and perimeter with
a digitizing program (Motic Images Plus 2.0, Motic China
Group Co. Ltd, Xiamen, China). The number of hatched
embryos was counted at 48 h in culture.
Blastocyst attachment
After 48 h in culture, hatched blastocysts were transferred
to HECM-2h medium containing 10% fetal bovine serum
(Invitrogen, Carlsbad, CA, USA). They were cultured for a
further 24 h under the same condition. The number of
attached embryos was counted on day 3 of culture. Images
of attached embryos were captured for measurement of
area/perimeter as described in the last section.
Differential staining of inner cell mass (ICM) and 
trophectoderm (TE) of cultured blastocysts
The differential staining of ICM and TE was modified
from Handyside and Hunter [17]. Blastocysts at 72 h.pc
were flushed from excised uterine horns and cultured for
24 h in hatching medium with and without GDF-8. The
zona pellucida of cultured blastocysts were removed by
acid Tyrode's solution and incubated in HECM-2h for 15-
30 min. The zona-free blastocysts were treated with 1:5
diluted anti-hamster whole serum for 15 min at 37°C,
washed in the medium and incubated in 1:5 diluted
guinea pig complement serum together with 25 μg/ml
propidium iodide (PI) for 20 min at 37°C or until all TE
cells were stained with PI. After rinsing in PBS, the blasto-
cysts were stained with Hoechst 333258 (25 μg/ml) and
mounted in glycerol. The cells of ICM and TE which
respectively appeared pink and blue when excited by UV
were counted with a fluorescent microscope (ST-18; Carl
Zeiss, Oberkochen, Germany).
Statistical analysis
GDF-8 data obtained by real time PCR and Western blot-
ting at designated days of pregnancy were compared with
value for the day of estrous by Student's t-test. To deter-
mine the effect of the presence of embryos on active GDF-
8 level in the uterus, one way ANOVA was used to analyse
data across all time points. The percentages of proliferat-
ing MSMC and EEC with and without GDF-8 treatment
were compared by Student's t-test. Student's t-test was also
used to compare LIF released into the medium of EEC cul-
tures with and without exogenous GDF-8. Student's t-test
and χ2test were used to determine if GDF-8 had an effect
on the number of embryos, TE cells and ICM cells in cul-
ture. The level of significance for all statistical analyses was
set at P < 0.05.
Results
Identification of proteins of interest in uterine fluid and 
confirmation of GDF-8 in uterine fluid
Figure 1 shows eight proteins of interest from the hamster
72 hpc uterine fluid. Table 2 summarizes the MASCOT
score and observed physical parameters of the identified
spots. Only GDF-8 was selected for further study because
its functional significance in the uterus had never been
investigated.Reproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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2D separation of proteins in hamster 72 h post coital uterine fluid Figure 1
2D separation of proteins in hamster 72 h post coital uterine fluid. Proteins in uterine fluid were separated by 2D-
electrophoresis (Number of animals = 9). The gel was stained with silver nitrate and spots picked, digested with trypsin and 
analyzed by MALDI-TOF. Eight protein spots of interest were identified (marked in red circle and enlarged in inserts).
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Spot 7—Osteoclast differentiation
factor (ODF)
Spot 1—Prolactin-like protein F
Spot 5 —Prolactin-like protein I
Spot 8—Tumor necrosis factor alpha
induced protein 6 (TSG6)
Spot 6—Growth differentiation
factor 8 (GDF-8)
Spot 2—Alpha-2μ μ μ μ globulin PGCL5
Spot 3—Trypsin-like protease p98
Spot 4 —Interleukin 12b p40 subunit
Table 2: Summary of proteins identified by MALDI-TOF.
Spot No. Protein Identity MOWSE Score Matched No./Total 
No. (%)
Accession No. Observed MW 
(×103)/pI
Theoretical MW 
(×103)/pI
1 Prolactin-like protein F 3.67 6/39 (15) 11968116 28/4.6 29/4.6
2 Alpha-2 μglobulin 
PGCL5
1045 11/62 (17) 22219456 22/6.1 21/6.1
3 Trypsin-like protease 
p98
2.41e4 14/125 (11) 31542447M 40/8.3 42/8.5
4 Interleukin 12b p40 
subunit
4772 15/108 (13) 6652948M 36/6.1 38/6.1
5 Prolactin-like protein I 720 10/78 (12) 13385390 25/5.2 26/5.2
6 Growth-differentiation 
factor-8 (GDF-8)
3.50e4 20/91 (21) 6754752 45/6.3 43/6.6
7 Osteoclast 
differentiation factor 
(ODF)
2038 8/70 (11) 4127270 35/7.7 35/78
8 Tumor necrosis factor-
induced protein 6 
(TSG6)
1.7e0.8 25/136 (18) 6678379 33/7.4 31/7.6
Nine proteins of interest in hamster 72 h post coital uterine fluid were identified. Information was obtained from on-line database Protein 
Prospector 4.0.5 provided by University of California, San Francisco http://prospector.ucsf.edu/.Reproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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Figure 2 displays the raw spectrum of GDF-8 from
MALDI--TOF. (For the raw spectra of other proteins, see
Additional file 1; Figure S1.) GDF-8 in the hamster uterus
had a molecular size of 45 kDa and a pI of 6.7. The iden-
tity of GDF-8 was confirmed by immunoblotting. Uterine
fluid was separated by 2D gel electrophoresis, transblot-
ted onto nitrocellulose membrane and probed with anti-
GDF-8 antibody; a spot at the same location confirmed
the presence of GDF-8 (Figure 3).
Molecular cloning of hamster GDF-8
Primers designed according to homologous regions of
GDF-8 in mouse and rats were used to produce a 342 bp
amplicon which was cloned and sequenced in hamster
uterine tissues (Figure 4). The hamster sequence (exclud-
ing primer regions) was found to share respectively 94%,
94% and 92% homology with the mouse, rat and human
(Figure 5) which implied that the cloned region was a
conserved region of GDF-8 in these species.
Representative spectrum of GDF-8 obtained from MALDI-TOF analysis Figure 2
Representative spectrum of GDF-8 obtained from MALDI-TOF analysis. The protein spots were picked from ham-
ster 72 h post coital uterine fluid 2-D gels. Each protein spot was digested by trypsin overnight, mixed with matrix and placed 
on sample plate for analysis. Each peak on the spectrum represents a single digested peptide, with its mass annotated).
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Confirmation of GDF-8 in hamster uterine fluid by western  blotting Figure 3
Confirmation of GDF-8 in hamster uterine fluid by 
western blotting. Proteins in 72 h post coital uterine fluid 
were separated by 2D-electrophoresis and transblotted onto 
nitrocellulose membrane. GDF-8 (green circle) was identified 
by probing with goat polyclonal anti-GDF-8 antibody and vis-
ualized with ECL Plus kit).
Gene expression of GDF-8 in hamster 72 h post coital uter- ine tissue Figure 4
Gene expression of GDF-8 in hamster 72 h post coital 
uterine tissue. GDF-8 mRNA was amplified with uterine 
RNA as template. The 342 bp PCR product was cloned and 
sequenced to unveil the hamster GDF-8 sequence).Reproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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Estimation of uterine GDF-8 mRNA and peptide during 
pregnancy
Figure 6A illustrates changes of GDF-8 mRNA during the
course of pregnancy; data were expressed as fold change
relative to an arbitrary baseline at estrus. GDF-8 mRNA
dropped significantly from D3 and stabilized at a signifi-
cantly lower level from D9 onwards. Since hamster
embryo normally crossed the oviduct-uterus boundary at
D3; data from D3 to D15 was compared with that from
D2.5 to find out if the presence of embryos had any effect
on uterine GDF-8 mRNA level. A significant reduction was
registered at D9. As shown in Figure 6B, the amount of
functionally active (cleaved) form of GDF-8 peptide was
significantly higher during pregnancy, being highest at D3
when the embryo reached the uterus (P < 0.01 at D3, D5
and D9 compared with D2.5).
Localization of GDF-8 mRNA and peptide in the uterus
In situ hybridization localized GDF-8 transcripts to the
luminal epithelium only (Figure 7A and 7B) while no sig-
nal was obtained when the sense probe was used (Figure
7C). Intense immunoreactivity to GDF-8 antibody was
observed in cells of the stroma (Figure 7D and 7E) but not
the epithelium and myometrium. We suggest that GDF-8
was synthesized in the epithelium but the protein was
either released into the uterine fluid or accumulated in the
stroma.
GDF-8 slowed down proliferation of myometrial smooth 
muscle cells (MSMC)
About 64.14 ± 0.04% of cells in the MSMC primary cul-
ture were positive for the antibody to α-smooth muscle
actin (SMA). These cells also expressed activin receptor
type II (ACVR2, data not shown). Administration of GDF-
8 at 5 μg/μl for 60 h or 72 h did not change the number
of SMA-positive cells but did significantly reduced the
number of proliferating cells (P < 0.05) (Figure 8). So
GDF-8 curtailed proliferation of myometrial cells.
GDF-8 slowed down proliferation and differentiation of 
endometrial epithelial cells (EEC) and reduced their LIF 
secretion
Our preliminary data revealed that EEC also expressed
ACVR2 (data not shown), so a primary culture of EEC was
set up to investigate the effect of GDF-8 on EEC. EEC was
identified by its marker, keratin and the purity of culture
was 82.85 ± 6.03. When treated with GDF-8 (5 μg/μl) for
36 h, the numbers of EEC and proliferating EEC both
Homology of hamster GDF-8 sequence with human, rat and mouse sequences Figure 5
Homology of hamster GDF-8 sequence with human, rat and mouse sequences. The hamster GDF-8 mRNA was 
cloned, sequenced and aligned against human, mouse and rat sequences. They shared over 90% homology).Reproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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decreased (P < 0.001) (Figure 9A). This suggests that GDF-
8 exerted a negative effect on proliferation and differenti-
ation of EEC. Figure 9B shows that LIF in the culture
medium was significantly lowered by exogenous GDF-8.
This could be due to fewer EEC in the culture or a direct
effect of GDF-8 on EEC release of LIF.
GDF-8 stimulated trophectoderm cell proliferation of 
preimplantation embryos and promoted hatching
The presence and peaking of GDF-8 in the uterus at D3 of
pregnancy implied a possible trophic effect on the
implanting embryo [12]. To test this, hamster blastocysts
were put in culture and treated with GDF-8 (0.75 μg/ml)
for 24 h or 48 h. After 24 h incubation, blastocytes were
significantly larger as reflected by area and perimeter
(Table 3) and this effect sustained as incubation contin-
ued to 48 h. The significant increase in total cell number
of treated blastocytes was attributed solely to proliferation
in the trophectoderm (TE). Cells in the inner cell mass
(ICM) remained unchanged. GDF-8 however, reduced the
attachment area and perimeter by over 40% (p < 0.001)
and 30% (p < 0.01) respectively. These data suggested that
GDF-8 modulated the implantation process.
Discussion
Structural transformation and functioning of the pregnant
uterus are largely controlled by steroid hormones, and
fine-tuned by signalling molecules, growth factors,
immune modulators and adhesion factors. Using pro-
teomic techniques, we profiled some peptides present in
the 72 hpc uterine fluid of the golden hamster. Several
proteins were subjected to further study and they included
growth factors, immunomodulators and hormone-related
proteins. We selected GDF-8 for functional study because
of its potential importance in female reproduction.
GDF-8 is normally associated with development of skele-
tal muscles [7]. Its presence in the non-pregnant uterus of
the human [18] and rat [10] has been reported. It may
play a regulatory role in follicular development of bovine
and [19] murine species [20]. Other GDF isoforms have
been found in the female reproductive system. They
include GDF-9 that regulates folliculogenesis and ster-
oidogenesis in ovine and bovine ovaries [19,21,22]; GDF-
10 even though present in both pregnant and non-preg-
nant uterus, appears to be redundant [23]; GDF-5 and
GDF-11 are also found in the human endometrium dur-
ing the secretary phase [18]. Other than these, informa-
tion on functional significance of GDF is wanting.
In this study, we identified GDF-8 and explored its possi-
ble role in pregnancy. We detected by in situ hybridization
GDF-8 mRNA in endometrial epithelium. GDF-8 protein
was identified in uterine fluid by electrophoresis and con-
firmed by Western blotting. Immunohistochemistry local-
Figure 6
Temporal profile of GDF-8 in hamster uterus during
pregnancy: (A) mRNA expression and (B) cleaved
form of the protein. Total RNA from uterus collected at
designated time points post coitus was extracted, reversely-
transcribed and subjected to real time PCR for amplification
of GDF-8. Data were expressed as mean ± S.E.M. To deter-
mine how pregnancy affected GDF-8 expression, data from
pregnant uterus was compared with non-pregnant uterus at
day of estrous (D0) by Student's t-test (*P < 0.05; ***P <
0.01) (Number of animals: D0:6; D2.5:4, D3:4, D5:3, D7:5,
D9:5, D15:4). There was a significant reduction in GDF-8
mRNA from D3 onwards. At D2.5 (open squares) the uterus
was free of embryos. From D3 onwards (closed squares),
embryos were in the uterus. To find out if the presence of
embryos affected GDF-8 mRNA expression, data from D3 to
D15 were compared with that of D2.5 by one-way ANOVA
and a significant decrease was noted only in the D9 uterus #P
< 0.05). (B) Total uterine proteins at various post coital time
points were extracted to determine the amount of active
GDF-8 peptide by ELISA. Likewise, data were expressed as
m e a n  ±  S . E . M .  D a t a  f r o m  p r egnant uteri (closed squares)
were compared with that of non-pregnant uterus at estrus
(D0, open squares) by Student's t-test (***P < 0.01) (Number
of animals at each time point =3). The amount of active GDF-
8 in pregnant uterus was significantly higher than that of non-
pregnant uterus. One-way ANOVA was used to determine
the effect of the presence of embryos in uterus on active
GDF-8 level. The presence of embryo at D3, D5 and D9 has
significantly higher level of active GDF-8 (#P < 0.05; ###P <
0.01 compared with D2.5).

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ized its accumulation in endometrial stroma. Its receptor
ACVR2 has been localized in all cell types in the uterus of
the sheep and pig [24,25]. When we treated primary cul-
tures of myometrial cells (MSMC) and epithelial cells
(ECC) with the active GDF-8 peptide, we observed slow-
ing down of proliferation of both cell types which is in
line with the well-established anti-proliferative action of
GDF-8 on skeletal muscle cells [26,27]. In the EEC pri-
mary culture, we noticed that GDF-8 treatment is associ-
ated with a reduction of LIF in the medium. This can be a
consequence of fewer EEC in culture or a negative effect
on release of LIF by EEC. LIF is one of the key inflamma-
tory modulators for implantation [28]. Implantation can
be prevented by blocking the action of LIF with its pegly-
ated antagonist [29]. So it is reasonable to suggest that
directly or indirectly, GDF-8 may immunomodulate the
uterine microenvironment. By real time PCR, we found
that GDF-8 gene expression level declined as pregnancy
progressed, to reach its nadir during late pregnancy. The
amount of active form of GDF-8 peptide also declined.
This suggests that GDF-8 is more active in early pregnancy.
In our hamster model, the timing is in phase with implan-
tation of embryo when cell division in the uterus is vigor-
ous; thus highlighting the importance of GDF-8 in fine-
tuning receptivity of the endometrium.
As for the embryo, GDF-8 is embryotrophic (Table 3).
After 24 h in culture with GDF-8, the embryo became
larger (area and perimeter when flattened) and its cell
number increased significantly. A breakdown into ICM
and TE cells by differential staining showed that the stim-
ulatory effect was limited to the TE only. Enlargement of
Localization of GDF-8 transcripts by in situ hybridization (A and B) and peptide by immunohistochemistry (C and D) in the  hamster 72 h p.c. uterus Figure 7
Localization of GDF-8 transcripts by in situ hybridization (A and B) and peptide by immunohistochemistry (C 
and D) in the hamster 72 h p.c. uterus. (A) Low magnification of uterine cross section to show that GDF-8 mRNA was 
confined to endometrial epithelium. (B) Insert magnified to show intense signals in epithelial cells. (C) Absence of signals in neg-
ative control of ISH with the sense probe. (D and E) Immunostaining localized GDF-8 peptide to the endometrial stroma (s), 
but not the myometrium (m) and epithelium (e) (Number of animals =3). Bar = 100 μm).
Effect of GDF-8 on proliferation of hamster myometrial  smooth muscle cells (MSMC) in primary culture Figure 8
Effect of GDF-8 on proliferation of hamster myome-
trial smooth muscle cells (MSMC) in primary culture. 
GDF-8 (5 μg/ml) suppressed the proliferation of MSMC. The 
percentage of proliferating MSMC was compared with the 
control by Student's t-test (*P < 0.05).Reproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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the blastocoel could also imply an action of GDF-8 on the
basolateral Na+-K+ATPase system that mediates the cou-
pled transport of water across the TE [30]. Interestingly,
culture of embryos in GDF-8 for 48 h hastened hatching
but discouraged attachment which could lead to poorer
implantation. To explain this dilemma, we propose that
GDF-8 could impair expression of the embryonic implan-
tation serine proteinase (ISP1) gene [31]. All in all, our
present results together with the reported finding that
GDF-8 could perturb glucose metabolism in human pla-
centa [32], suggest a possible role for GDF-8 in placental
development and function.
It has been suggested that GDF-8 released into the uterine
environment is beneficial to the developing conceptus
because GDF-8 may prevent excessive muscle growth [18].
Evidence to support such a view comes from the fact that
administration of soluble form of ACVR2B enhances
embryo muscular growth [8]; also a dam which has been
immunized with GDF-8 gives birth to offspring with
altered composition of crude protein and fat in the body
[20]. Apart from muscle, GDF-8 could restrict osteogene-
sis [33] and promote neurite outgrowth of retinal gan-
glion cells [34]. As for its origin, GDF-8 is said to be a
placental product [32], and in this investigation, we recog-
Effect of GDF-8 on hamster endometrial epithelial cells (EEC) in primary culture Figure 9
Effect of GDF-8 on hamster endometrial epithelial cells (EEC) in primary culture. (A) EEC in primary culture were 
treated with GDF-8 (5 μg/ml) for 36 h. The percentages of EEC and proliferating EEC were compared with untreated cells by 
Student's t-test (***P < 0.001). (B) LIF secretion by EEC into the culture medium was determined by ELISA. Data from GDF-8 
treated samples was compared with untreated ones by Student's t-test (*P < 0.05). All experiments were repeated four times).
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nized the uterus as the source of GDF-8. It remains to be
clarified if the conceptus also secretes GDF-8.
Conclusion
We report here the identification of GDF-8 in the mam-
malian pregnant uterus. We noticed that the quantity of
GDF-8 mRNA and active peptide both declined as preg-
nancy progressed, possibly to the advantage of the con-
ceptus for not restricting its growth. Uterine GDF-8 mRNA
was localized to luminal epithelial cells but the protein
accumulated in endometrial stroma to act on the epithe-
lial cells and myometrial smooth muscle cells in a para-
crine manner. With regard to the embryo, the action of
GDF-8 is mixed. It stimulated proliferation of TC cells and
hatching but discouraged attachment. The latter could
possibly be due to disturbance to embryonic implantation
protease expression or attenuation of LIF production by
endometrial epithelialium. In view of its multi-faceted
action on the uterus and embryo, it will be useful to
explore the full potential of GDF-8 as a non-hormonal
contraceptive and to ascertain its unfavourable side effects
in reproductive toxicology because GDF-8 is regarded as a
novel therapeutic target for certain metabolic disorders
[35].
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Table 3: Effects of GDF-8 on hamster blastocysts in culture.
Treatment Control GDF-8 (0.75 μg/ml)
No. of Embryos (at 72 hpc)1 4 8 5 3
Area of embryo image (μm2) 5639.8 ± 125.4 7901.1 ± 317.0***
Perimeter of embryo image (μm) 266.1 ± 2.8 311.8 ± 6.5***
24 h in culture
No. of embryos reaching late/expanded blastocyst 82 43
No. of trophectoderm (TE) cells 26.9 ± 1.2 37.6 ± 1.4***
No. of Inner Cell Mass (ICM) cells 15.3 ± 0.7 16.9 ± 0.7
TE/ICM 2.1 ± 0.1 2.4 ± 1.1
Total cell number 42.2 ± 1.3 54.5 ± 1.5***
48 h in culture
No. of embryos 70 50
Area (μm2) 5951.6 ± 218.7 9911.1 ± 648.6***
Perimeter (μm) 280.1 ± 4.8 355.9 ± 10.8***
Hatching
% embryos hatched (hatched/total No.) 56.9(70/123) 94.3(50/53)++
Attachment
No. of embryos 69 50
Area (μm2) 21612 ± 1668 12109 ± 1036***
Perimeter (μm) 603.3 ± 36.1 424.7 ± 21.1**
Number of embryos, TE and ICM without treatment were compared with that of treated embryos with Student's t-test; *P < 0.05; **P < 0.01; ***P 
< 0.001 compared with control; ++P < 0.001 compared with control using χ2 testReproductive Biology and Endocrinology 2009, 7:134 http://www.rbej.com/content/7/1/134
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